ProfileGDS4132 / 221512_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 80% 79% 83% 78% 71% 77% 79% 79% 75% 77% 76% 75% 76% 79% 72% 66% 70% 78% 79% 70% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101265.50780
GSM201543Muscle PCOS pioglitazone 121253.87779
GSM201544Muscle PCOS pioglitazone 161320.90183
GSM201545Muscle PCOS pioglitazone 201281.73178
GSM201829Muscle PCOS pioglitazone 231224.00371
GSM201830Muscle PCOS pioglitazon 251256.14177
GSM201831Muscle PCOS pioglitazone 271274.26379
GSM201832Muscle PCOS pioglitazone 31255.86179
GSM201833Muscle PCOS pioglitazone 41229.2975
GSM201834Muscle PCOS pioglitazone 81254.06977
GSM201835Muscle PCOS after pioglitazone 102245.87976
GSM201836Muscle PCOS after pioglitazone 122232.6575
GSM201837Muscle PCOS after pioglitazone 162232.69176
GSM201838Muscle PCOS after pioglitazone 202278.17179
GSM201839Muscle PCOS after pioglitazone 232219.64672
GSM201840Muscle PCOS after pioglitazone 252190.43466
GSM201841Muscle PCOS after pioglitazone 272194.95570
GSM201842Muscle PCOS after pioglitazone 32233.35878
GSM201843Muscle PCOS after pioglitazone 42267.25179
GSM201844Muscle PCOS after pioglitazone 82212.80270